IMNP

Immune Pharmaceuticals Inc.
IMNP

Delisted

IMNP was delisted on the 25th of July, 2018.

14 hedge funds and large institutions have $845K invested in Immune Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$584K 2,083,915 +1,871,015 +879%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$67K 242,723 +142,804 +143%
Goldman Sachs
3
Goldman Sachs
New York
$44K 156,868 +156,868 New
VKH
4
Virtu KCG Holdings
New York
$43K 151,047 +136,060 +908%
Renaissance Technologies
5
Renaissance Technologies
New York
$43K 152,498 +152,498 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$24K 86,812 +86,812 New
UBS Group
7
UBS Group
Switzerland
$18K 63,449 +63,448 +6,344,800%
TSS
8
Two Sigma Securities
New York
$9K 31,509 +31,509 New
EEG
9
E.E. Geduld
$7K 25,000
IFS
10
Ifrah Financial Services
Arkansas
$4K 13,000
BFA
11
BlackRock Fund Advisors
California
$2K 6,771 +747 +12%
SCM
12
Sio Capital Management
New York
-197,655 Closed
Bank of America
13
Bank of America
North Carolina
$0 31 -386 -93%
Morgan Stanley
14
Morgan Stanley
New York
-69 Closed
Deutsche Bank
15
Deutsche Bank
Germany
$0 28
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$0 2,000 +1,000 +100%